Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18

By Business Wire,  March 11, 2013, 08:00:00 AM EDT


SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics Inc. (NASDAQ:CYTX) will present and provide a corporate update from the 25th Annual Roth Conference on Monday, March 18 at 4:30 PM PT.

The presentation will be webcast and may be accessed under "Webcasts" under Cytori's Investor Relations section of the website. The webcast can be viewed live and will be available for replay after the presentation on the Company's website.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family. www.cytori.com

Source: Cytori Therapeutics, Inc.


This article appears in: News Headlines

Referenced Stocks: CYTX



Latest News Video

Hanson Brothers Create 'Mmmhops' Beer
Hanson Brothers Create 'Mmmhops' Be...
French Soldier Stabbed in Neck in Paris
French Soldier Stabbed in Neck in P...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.24 0.03  0.23%
FB $ 24.32 0.74  2.95%
SIRI $ 3.58 0.04  0.99%
GE $ 23.53 0.13  0.55%
PFE $ 29.04 0.07  0.24%
MSFT $ 34.27 0.12  0.35%
INTC $ 23.93 0.12  0.50%
P $ 16.43 0.73  4.25%